ACCESSION: MSBNK-SMB_Measured-HSA014P0174001
RECORD_TITLE: Annotated; N-Acetyl-L-aspartic acid; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL23-neg_1495': {'bp': 271562.0, 'sum': 729975.0}, 'EL11-neg_1490': {'bp': 264921.0, 'sum': 641413.0}, 'EL03-neg_1491': {'bp': 256479.0, 'sum': 773421.0}, 'EL24-neg_1485': {'bp': 255895.0, 'sum': 630227.0}, 'EL20-neg_1497': {'bp': 255534.0, 'sum': 682416.0}, 'EL21-neg_1492': {'bp': 246242.0, 'sum': 626688.0}, 'EL10-neg_1500': {'bp': 246195.0, 'sum': 567114.0}, 'EL18-neg_1491': {'bp': 240630.0, 'sum': 657736.0}, 'EL15-neg_1498': {'bp': 239007.0, 'sum': 621286.0}, 'EL13-neg_1496': {'bp': 233755.0, 'sum': 585734.0}, 'EL16-neg_1488': {'bp': 230419.0, 'sum': 696122.0}, 'EL14-neg_1494': {'bp': 229832.0, 'sum': 574800.0}, 'EL08-neg_1490': {'bp': 229038.0, 'sum': 565739.0}, 'EL10-neg_1427': {'bp': 228418.0, 'sum': 750581.0}, 'EL19-neg_1497': {'bp': 228298.0, 'sum': 587576.0}, 'EL04-neg_1492': {'bp': 223094.0, 'sum': 572468.0}, 'EL05-neg_1500': {'bp': 222905.0, 'sum': 563426.0}, 'EL17-neg_1492': {'bp': 213766.0, 'sum': 564321.0}, 'EL09-neg_1497': {'bp': 208464.0, 'sum': 508658.0}, 'EL01-neg_1495': {'bp': 208029.0, 'sum': 524245.0}, 'EL22-neg_1502': {'bp': 207738.0, 'sum': 543496.0}, 'EL07-neg_1423': {'bp': 207630.0, 'sum': 680240.0}, 'EL06-neg_1496': {'bp': 207027.0, 'sum': 610940.0}, 'EL02-neg_1506': {'bp': 182782.0, 'sum': 529817.0}}
COMMENT: RETENTION_TIME_STDEV 0.033
COMMENT: PRECURSOR_M/Z_RAW 174.039822
COMMENT: PRECURSOR_M/Z_STDEV 0.000066
COMMENT: PRECURSOR_IN_MS1 mz 174.040209; int 30.620; delta(ppm) 3.328249
COMMENT: PROPOSED_CHARGE_STATE -1; mz 175.043665; int 1.892; cor 0.752
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 3.422; C6H9NO5; [M-H]1; delta(ppm) -3.421929
COMMENT: PROPOSED_MF MS-FINDER 3.579; C6H9NO5; [M-H]-; delta(ppm) -3.441564
COMMENT: PROPOSED_MF SIRIUS5_Sirius 28.567; C6H9NO5; [M-H]-; delta(ppm) -3.441564
COMMENT: PROPOSED_MF SIRIUS5_Sirius 10.391; C7H5N5O; [M-H]-; delta(ppm) -11.125965
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.372; C7H13NS2; [M-H]-; delta(ppm) -8.434706
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.693; C10H9NS; [M-H]-; delta(ppm) 10.935165
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) -3.441564
COMMENT: PROPOSED_MF SIRIUS6_Sirius 42.410; C6H9NO5; [M-H]-; delta(ppm) -3.441564
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.942; C4H7N4O4; [M-H]-; delta(ppm) 4.273117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.135; C4H8F3NO3; [M-H]-; delta(ppm) 10.608600
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.497; C5H13NO2Si2; [M-H]-; delta(ppm) -268693.653501
COMMENT: PROPOSED_MF SIRIUS6_Sirius 20.170; C7H5N5O; [M-H]-; delta(ppm) -11.125965
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.166; C12H5BO; [M-H]-; delta(ppm) 61047.559837
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.372; C7H13NS2; [M-H]-; delta(ppm) -8.434706
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.693; C10H9NS; [M-H]-; delta(ppm) 10.935165
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.709; C2H5F4N5; [M-H]-; delta(ppm) -3.641471
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.599; C7H6F3N2; [M-H]-; delta(ppm) -4.790677
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) -3.441564
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 18.000; OTCCIMWXFLJLIA-BYPYZUCNSA-N; C6H9NO5; N-Acetyl-L-aspartic acid - 40.0 eV
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; OTCCIMWXFLJLIA-UHFFFAOYSA-N; C6H9NO5; Massbank:PR100851 N-Acetyl-DL-aspartic acidAc-AspNAAN-Acetyl-aspartateN-Acetylaspartate2-acetamidobutanedioic acid
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.385; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; CC(=O)N[C@@H](CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.133; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; CC1(OC(=O)CC(C(=O)O1)N)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.133; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; CC(NC(=O)CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.900; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; N[C@@H]([C@@H](O)C(=C)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.863; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; OCC(=N)C1OC(=O)C(O)C1O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.981; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.616; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.408; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.382; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.350; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.325; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.278; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.246; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.246; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.007; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.990; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.956; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.924; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.915; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.913; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.897; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.887; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.844; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.807; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.956; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; (2S)-2-acetamidobutanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.313; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; (2S)-2-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.292; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.242; AZKKNWAHCAZDCU-UHFFFAOYSA-N; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.070; HQESMQVYRAJTEA-UHFFFAOYSA-N; [M-H]-; 4-(carboxymethylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; VZRHBEPCALFDTQ-UHFFFAOYSA-N; [M-H]-; methyl 3-(methoxycarbonylamino)-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.823; NWWNMEXBDCKKIG-JLAZNSOCSA-N; [M-H]-; (2R)-2-[(1S)-2-amino-1-hydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; JHLJBMKXTOOGCW-AIHAYLRMSA-N; [M-H]-; (3aS,5R,6R,6aR)-6-hydroxy-5-(hydroxymethyl)-3a,5,6,6a-tetrahydro-3H-furo[2,3-d][1,3]oxazol-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -6.948; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.744; AZKKNWAHCAZDCU; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.204; QXAHNKVDGAGBNU; [M-H]-; 3-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.029; WRDWXTJVALMCAN; [M-H]-; N-(Vinyloxycarbonyl)-L-serine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.844; ADZLWSMFHHHOBV; [M-H]-; formylglutamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.621; HXWZRYKURKEOSO; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.278; BNJOZDZCRHCODO; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.598; RSYBGFZORPFBEV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -335.710; SPJCNQDVYQSGSB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.065; NWWNMEXBDCKKIG; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -375.820; RTPBEMVDAXPYRC; [M-H]-; Scorbamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.746; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -22.058; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.289; AZKKNWAHCAZDCU; [M-H]-; 2-(2-carboxyacetamido)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -201.101; FOCKMBBVQYRNGP; [M-H]-; Propanedioic acid, (methoxyimino)-, dimethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -208.209; XYNXPKJAVYJHOF; [M-H]-; 3-Acetylaspartic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.839; ZQWAVKINQMTJSS; [M-H]-; 3-[(Carboxycarbonyl)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -215.916; ISTWWSBLMQHYIQ; [M-H]-; N-oxalyl-alpha-methylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -218.305; HQESMQVYRAJTEA; [M-H]-; 4-(Carboxylatomethylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -219.892; WRDWXTJVALMCAN; [M-H]-; 2-(Ethenoxycarbonylamino)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.261; BNJOZDZCRHCODO; [M-H]-; Dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -221.888; QXAHNKVDGAGBNU; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.981; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match N-Acetyl-L-aspartic acid, OTCCIMWXFLJLIA-BYPYZUCNSA-N; Matching to 18 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (3), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0000812;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H9NO5
CH$EXACT_MASS: 175.048072
CH$SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)O
CH$IUPAC: InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1
CH$LINK: CHEBI CHEBI:16953
CH$LINK: HMDB HMDB0000812
CH$NAME: N-Acetyl-L-aspartate
CH$NAME: N-Acetyl-L-aspartic acid
CH$NAME: (2S)-2-acetamidobutanedioic acid
CH$LINK: INCHIKEY OTCCIMWXFLJLIA-BYPYZUCNSA-N
CH$LINK: PUBCHEM CID:65065
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.543
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 174.040197
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0002-9600000000-c3df820075563fe73870
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0284374 76.0635 58.028413 1.0684 43.61 0.8647 23 ?
  59.0124170 36.1790 59.012392 1.0845 21.61 0.8584 24 ?
  71.0123734 19.0562 71.012355 1.2955 9.66 0.7338 21 ?
  88.0389727 208.4105 88.038970 0.7610 117.36 0.8416 24 ?
  97.9299519 66.4839 97.929962 0.8475 9.87 0.0586 23 ?
  99.9244032 999.0000 99.924416 0.6005 0.00 0.1039 24 ?
  100.9245580 70.4224 100.924572 1.0206 6.12 -0.0506 24 ?
  100.9517320 21.4220 100.951746 1.1491 5.46 0.1929 18 ?
  111.0074370 43.2308 111.007467 0.9639 19.38 0.1509 22 ?
  114.0182985 29.0656 114.018334 0.9560 16.86 0.7632 22 ?
  114.9326892 20.5331 114.932727 1.1485 5.68 -0.2256 23 ?
  115.9193792 26.1528 115.919418 0.9662 5.35 -0.1494 24 ?
  116.9272086 309.6600 116.927250 0.5645 18.31 -0.0234 24 ?
  116.9459768 44.2184 116.946018 1.6589 10.33 0.0779 24 ?
  117.9273306 14.8382 117.927374 1.7384 4.17 -0.0929 17 ?
  118.9649468 50.8229 118.964992 1.0003 8.65 -0.1965 22 ?
  130.0496201 34.1551 130.049688 1.5225 19.32 0.9088 18 ?
  131.8750292 21.8590 131.875101 0.9100 5.73 -0.1393 20 ?
  144.9417666 13.3565 144.941871 1.8007 4.36 0.4441 18 ?
  146.9600001 92.4732 146.960110 0.8506 14.50 -0.4247 24 ?
  174.0398266 25.5631 174.040019 1.3675 16.10 1.0000 21 f{C6H8N1O5}/-5.57ppm,p
  174.8621063 37.3086 174.862302 1.2924 5.41 0.2912 19 ?
  189.8504751 106.8911 189.850248 0.6531 8.31 0.1623 24 ?
  190.8485396 76.7921 190.848231 1.0060 11.89 -0.0117 24 ?
PK$NUM_PEAK: 24
PK$PEAK: m/z int. rel.int.
  58.028437 76.06 76
  59.012417 36.18 36
  71.012373 19.06 19
  88.038973 208.41 208
  97.929952 66.48 66
  99.924403 999.00 999
  100.924558 70.42 70
  100.951732 21.42 21
  111.007437 43.23 43
  114.018298 29.07 29
  114.932689 20.53 20
  115.919379 26.15 26
  116.927209 309.66 309
  116.945977 44.22 44
  117.927331 14.84 14
  118.964947 50.82 50
  130.049620 34.16 34
  131.875029 21.86 21
  144.941767 13.36 13
  146.960000 92.47 92
  174.039827 25.56 25
  174.862106 37.31 37
  189.850475 106.89 106
  190.848540 76.79 76
//
